Life Sciences

Patient-centric digital companion
products for marketed therapies

Huma's digital companion products complement existing treatments, empowering and connecting patients, clinicians and healthcare systems to improve quality of care and simplify patient data capture.

Talk to our team

The current situation

The unmet need for patients, clinicians
and healthcare systems

Digitalisation has become a strategic priority across life sciences stakeholders, especially in regards to remote monitoring. Additionally, the benefit of preventative health is increasingly being considered by health-conscious consumers who are open to share data and voluntarily track themselves with apps, wearables, and other devices.

Improving marketed
therapies

Huma’s digital companion products complement existing treatments and care pathways by empowering patients to better understand and manage their own health. Companion products enable direct communication and data sharing amongst all life sciences stakeholders, which transforms care, improves adherence, and clinical decision-making.

The opportunity in
patient adherence

45% of patients with chronic conditions show medication non-adherence, causing at least 100,000 preventable deaths and $100 billion in preventable medical costs per year 1.

Illustration of man taking medicine.
Our solution

Huma’s digital companion products increase patient adherence through medication reminders, providing visibility of medication adherence to care teams, and empowering patients to take control of their own health.

The opportunity in
evidence collection

Real world evidence is increasingly being used by life science companies to help demonstrate a product's comparative effectiveness, safety and value in the real world 2.

Illustration of woman on laptop, heart and thermometer icons.
Our solution

Huma’s digital companion products support efficient prospective collection of real-world evidence, to help demonstrate the clinical and cost effectiveness of therapies and support market access and reimbursement decisions.

The opportunity in
data capture

Despite the 1:4 ratio between doctors and paper handling staff, 70% of specialists are collecting poor quality patient data 3.

Illustration of clinicians talking.
Our solution

Huma's digital companion products improve communication between patients and their care teams, streamline care pathways and simplify data capture.

  • patient adherence
  • Evidence collection
  • Data capture

Our offering

How digital
companion
products
can help you

Patients

Patients are more informed, motivated and empowered to take control of their own health.

Reduced anxiety as patients are guided every step of the way.

Personalised insights into their own health data and behaviours, empowering patients to improve their lifestyle and care.

Patients learn about themselves and are motivated to achieve a fast recovery & be more health conscious.

Access to discounts and rewards.

Streamlining care pathways, communication with care provider, and reducing clinical visits.

Clinicians

Precisely designed with clinical specialists.

Improved communication and interactions with patients and their caregivers.

Works alongside care team processes and workflows.

Improved adherence, reduced patient readmission and unnecessary hospital visits.

Streamlined care pathways and remote prioritisation and risk stratification of patients.

Early identification of patient deterioration - helping to reduce adverse outcomes.

Pharma

Enhance product through providing a personalised, engaging, supporting and empowering digital experience.

Support identification of patients in the real world that could benefit from treatment.

Gain insights from RWD and app usage that can improve understanding of long term safety, efficacy and patient behaviours.

Higher adherence to treatment schedule /care pathway to optimise outcomes.

Boosts loyalty through superior patient experience.

Build a long term relationship with patients.

Patients

Patients are more informed, motivated and empowered to take control of their own health.

Reduced anxiety as patients are guided every step of the way.

Personalised insights into their own health data and behaviours, empowering patients to improve their lifestyle and care.

Patients learn about themselves and are motivated to achieve a fast recovery & be more health conscious.

Access to discounts and rewards.

Streamlining care pathways, communication with care provider, and reducing clinical visits.

Clinicians

Precisely designed with clinical specialists.

Improved communication and interactions with patients and their caregivers.

Works alongside care team processes and workflows.

Improved adherence, reduced patient readmission and unnecessary hospital visits.

Streamlined care pathways and remote prioritisation and risk stratification of patients.

Early identification of patient deterioration - helping to reduce adverse outcomes.

Pharma

Enhance product through providing a personalised, engaging, supporting and empowering digital experience.

Support identification of patients in the real world that could benefit from treatment.

Gain insights from RWD and app usage that can improve understanding of long term safety, efficacy and patient behaviours.

Higher adherence to treatment schedule /care pathway to optimise outcomes.

Boosts loyalty through superior patient experience.

Build a long term relationship with patients.

  • Patients
  • Clinicians
  • Pharma

How it works

How do companion
products
complement
existing treatments
and
care pathways?

Identify/screen

Identify patients in the real world that could benefit from treatment and activate them. Perform screening assessments remotely to support assessment of individual treatment eligibility.

Prepare

Guide the patient through the care pathway. Help prepare for treatment at home or in the clinic.

Track

Track adherence to medication and provide reminders and notifications to prompt medication use.

Integrate

Integrate with portfolio of third party apps, 400+ connected wearable devices, or pull data directly from Apple HealthKit or Google Fit.

Educate

Trusted information on disease, treatment and potential side effects, how these can be managed, and when to seek medical advice. Access to FAQs and patient experiences.

Treat

Guide patients through taking their medication/ receiving their treatment in-clinic. Integrate with smart packaging/drug delivery devices where treatment is self directed.

Data collection

Select from a portfolio of 100+ modules to actively or passively monitor relevant signs, symptoms and adverse events.

  • Identify/screen
  • Educate
  • Prepare
  • Treat
  • Track
  • Data collection
  • Integrate

Identify patients in the real world that could benefit from treatment and activate them. Perform screening assessments remotely to support assessment of individual treatment eligibility.

Trusted information on disease, treatment and potential side effects, how these can be managed, and when to seek medical advice. Access to FAQs and patient experiences.

Guide the patient through the care pathway. Help prepare for treatment at home or in the clinic.

Guide patients through taking their medication/ receiving their treatment in-clinic. Integrate with smart packaging/drug delivery devices where treatment is self directed.

Track adherence to medication and provide reminders and notifications to prompt medication use.

Select from a portfolio of 100+ modules to actively or passively monitor relevant signs, symptoms and adverse events.

Integrate with portfolio of third party apps, 400+ connected wearable devices, or pull data directly from Apple HealthKit or Google Fit.

Why Huma?

Core benefits of
working with us

Scalable, turnkey solution

Huma’s modular digital health platform can be rapidly configured from an existing portfolio of over 100 data collection modules, to meet the needs of the target patient population and care pathway.

Adherence & user experience

We adopt a user-centric approach in every digital product we create, from mapping out the user journey and researching user needs, to extensive user testing and continuous improvement.

Machine learning & AI expertise

Extensive in-house data science team with deep understanding of and expertise in extracting novel insights from high dimensional datasets.

Data privacy & security

Data security and privacy controls compliant with international data privacy and security requirements.

Track record

Extensive track record in designing, developing and deploying digital health solutions, across 60 projects, in 20 therapeutic areas.

Globally deployable

Cloud agnostic platform that is ready to be deployed on any infrastructure and in any language.

Scalable, turnkey solution

Huma’s modular digital health platform can be rapidly configured from an existing portfolio of over 100 data collection modules, to meet the needs of the target patient population and care pathway.

Adherence & user experience

We adopt a user-centric approach in every digital product we create, from mapping out the user journey and researching user needs, to extensive user testing and continuous improvement.

Machine learning & AI expertise

Extensive in-house data science team with deep understanding of and expertise in extracting novel insights from high dimensional datasets.

Data privacy & security

Data security and privacy controls compliant with international data privacy and security requirements.

Track record

Extensive track record in designing, developing and deploying digital health solutions, across 60 projects, in 20 therapeutic areas.

Globally deployable

Cloud agnostic platform that is ready to be deployed on any infrastructure and in any language.

  • Scalable solution
  • user experience
  • Machine learning
  • Data privacy
  • Track record
  • Globally deployable
Dose tracker screenshot and device.
Dose tracker screenshot and device.

Case Study

BreeConnect®
app
supporting
Pulmonary
Arterial
Hypertension
(PAH)
patients

Huma has partnered with Bayer to develop BreeConnect® - a smartphone application that helps to support people with Pulmonary Arterial Hypertension (PAH) to track their medication doses and health-related quality of life.

BreeConnect® connects to the patients Breelib® nebuliser and tracks their medication doses against their prescribed medication regimen. BreeConnect® also enables the patient to track their physical activity, monitor their health related quality of life and share their data collected in the app with their care team.

Talk to us

This field is required

This field is required

This field is required

This field is required

Huma is committed to respecting your privacy, and we’ll only use your personal details to provide information you have selected you’re interested in. Review our Privacy Policy for further information.

We’d love to send you our monthly newsletter about our latest work, research and events by email. We’ll always treat your personal details with the utmost care and will never sell them to other companies for marketing purposes.

This field is required

I'm interested in
Healthcare – Better Care
Life Sciences – Better Research
Digital Biomarkers
Other

This field is required

Huma is committed to respecting your privacy, and we’ll only use your personal details to provide information you have selected you’re interested in. Review our Privacy Policy for further information.

We’d love to send you our monthly newsletter about our latest work, research and events by email. We’ll always treat your personal details with the utmost care and will never sell them to other companies for marketing purposes.

You’re in control. You can, of course, withdraw your consent at any time. Review our Privacy Policy for further information.

Success message with thumbs up for filling out the form.
One of our team members will be in touch with you shortly.
There was an error submitting your form. Please refresh and try again.
Sources
1.

Understanding Commonly Encountered Limitations in Clinical Research: An Emergency Medicine Resident’s Perspective. Jones, Christopher W. and Platts-Mills, Timothy F. MD (2011) https://www.ncbi.nlm.nih.gov/​pmc/articles/PMC3539753/

2.

Traditional and Digital Biomarkers: Two Worlds Apart. Babrak, L.M. and Menetski, J. (2019)

3.

Digital R&D: The Next Frontier for Biopharmaceuticals. McKinsey & Company (2017).
https://www.mckinsey.com/~/media/mckinsey/industries/pharmaceuticals%20and%20medical%20products/our%20insights/digital%20rd%20the%20next%20frontier%20for%20biopharmaceuticals/digitalrdthenextfrontierforbiopharma.pdf

Cookie settings

Read more